Your browser doesn't support javascript.
loading
Continuous lenalidomide treatment after bortezomib-melphalan-prednisolone therapy for newly diagnosed multiple myeloma.
Ishida, Tadao; Kimura, Hideo; Ozaki, Shuji; Kubo, Koumei; Sunami, Kazutaka; Takezako, Naoki; Fujita, Hiroyuki; Hayashi, Toshiaki; Kiguchi, Toru; Ohashi, Kazuteru; Yamamoto, Satoshi; Takamatsu, Hiroyuki; Kosugi, Hiroshi; Ohta, Kensuke; Sakai, Rika; Handa, Hiroshi; Kondo, Seiji; Abe, Yu; Omoto, Eijiro; Mitani, Kinuko; Morita, Satoshi; Murakami, Hirokazu; Shimizu, Kazuyuki.
Afiliación
  • Ishida T; Department of Hematology, Japanese Red Cross Medical Center, 4-1-22, Hiroo, Shibuya-ku, Tokyo, 150-8935, Japan. i.s.h.i.28@rondo.ocn.ne.jp.
  • Kimura H; Sapporo Medical University, Sapporo, Japan. i.s.h.i.28@rondo.ocn.ne.jp.
  • Ozaki S; Kita-Fukushima Medical Center, Date, Japan, Fukushima, Japan.
  • Kubo K; Tokushima Prefectural Central Hospital, Tokushima, Japan.
  • Sunami K; Aomori Prefectural Central Hospital, Aomori, Japan.
  • Takezako N; National Hospital Organization Okayama Medical Center, Okayama, Japan.
  • Fujita H; Disaster Medical Center of Japan, Tachikawa, Japan.
  • Hayashi T; Saiseikai Yokohama Nanbu Hospital, Yokohama, Japan.
  • Kiguchi T; Sapporo Medical University, Sapporo, Japan.
  • Ohashi K; Teine Keijinkai Hospital, Sapporo, Japan.
  • Yamamoto S; Chugoku Central Hospital, Fukuyama, Japan.
  • Takamatsu H; Tokyo Metropolitan Cancer and Infectious Disease Center, Komagome Hospital, Tokyo, Japan.
  • Kosugi H; Sapporo City General Hospital, Sapporo, Japan.
  • Ohta K; Kanazawa University, Kanazawa, Japan.
  • Sakai R; Ogaki Municipal Hospital, Ogaki, Japan.
  • Handa H; Osaka Saiseikai Nakatsu Hospital, Osaka, Japan.
  • Kondo S; Kanagawa Cancer Center, Yokohama, Japan.
  • Abe Y; Gunma University Graduate School of Medicine, Maebashi, Japan.
  • Omoto E; Saga-Ken Medical Center Koseikan, Saga, Japan.
  • Mitani K; Department of Hematology, Japanese Red Cross Medical Center, 4-1-22, Hiroo, Shibuya-ku, Tokyo, 150-8935, Japan.
  • Morita S; Yamagata Prefectural Central Hospital, Yamagata, Japan.
  • Murakami H; Dokkyo Medical University School of Medicine, Tochigi, Japan.
  • Shimizu K; Department of Biomedical Statistics and Bioinformatics, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Ann Hematol ; 99(5): 1063-1072, 2020 May.
Article en En | MEDLINE | ID: mdl-32248251
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Mieloma Múltiple Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Hematol Asunto de la revista: HEMATOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón